Antibody oligonucleotide conjugate (Avidity Bioscienecs/Eli Lilly)
N/A
Report date: 2026/01/26 17:59:02
Base Information
Drug NameAntibody oligonucleotide conjugate (Avidity Bioscienecs/Eli Lilly)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvidity Biosciences Inc
China Registration ClassN/A
Develop Information
Active CompaniesAvidity Biosciences Inc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A